300
Participants
Start Date
May 22, 2025
Primary Completion Date
March 15, 2027
Study Completion Date
March 15, 2028
FOLFOX4
FOLFOX4 was administered by oxaliplatin 85 mg/m² d1+ leucovorin 200 mg/m² d1-2+ fluorouracil 400 mg/m² 2 h→ 600 mg/m² 24 h d1-2 q2w, with a total of 4 cycles
Adebrelimab
Adebrelimab 1200mg, intravenous infusion, every 3 weeks
Apatinib
Apatinib 250mg, oral, once daily.
Icaritin
Epimedium extract soft capsules 2.4g, oral, 2 times daily.
SHR-1701
SHR1701,30mg/kg, intravenous infusion, every 3 weeks, use for up to 2 years at most.
QL1706
QL1706,5mg/kg, intravenous infusion, every 3 weeks, use for up to 2 years at most.
Bevacizumab
Bevacizumab 7.5mg, intravenous infusion, once every 3 weeks.
HAIC
Hepatic Arterial Infusion Chemotherapy
Local treatment
Local treatment of oligo-metastases.
The original treatment regimen
Continue the original targeted therapy combined with immunotherapy. dosage, dosage form,frequency of administration was the same as before.
RECRUITING
China Pharmaceutical University Affiliated Nanjing Tianyinshan Hospital, Nanjing
Nanjing Tianyinshan Hospital
OTHER